Vanessa King

Company: Daiichi Sankyo

Job title: Director Companion Diagnostics

Bio:

Vanessa King is currently a Director of Companion Diagnostics at Daiichi Sankyo where her primary focus is developing assays to predict response and efficacy for antibody drug conjugates. Before joining DSI from BMS, Vanessa oversaw the PD-L1 CDx program in the Diagnostic Sciences group, as well as led the digital pathology project with the goal of developing algorithms to interrogate the tumor microenvironment. Prior to working in pharma, Vanessa spent many years in clinical diagnostics where she worked with novel technologies developing cell and tissue-based and immunoassays.

Seminars:

Panel Discussion: What Will it Take to Standardize Spatial Across Industry & Who Should Lead the Charge? 9:40 am

What are the most critical barriers currently preventing standardization across spatial platforms, workflows, and datasets in biopharma? How do inconsistent tissue handling, assay protocols, and data formats affect cross-study comparability and regulatory acceptance? Should standardization start with biomarkers, instrumentation, data pipelines, or all at once? What should the priority be?Read more

day: Day One